PMID- 31368266 OWN - NLM STAT- MEDLINE DCOM- 20190807 LR - 20190807 IS - 1000-0607 (Print) IS - 1000-0607 (Linking) VI - 44 IP - 6 DP - 2019 Jun 25 TI - [Acupoint application of herbal paste relieves symptoms and naso-mucosal inflammatory response by down-regulating serum TGF-beta1 in allergic rhinitis rats]. PG - 430-3 LID - 10.13702/j.1000-0607.180369 [doi] AB - OBJECTIVE: To observe the effect of acupoint application of herbal paste on symptoms of allergic rhinitis (AR), serum immunoglobulin E (IgE) and transforming growth factor beta 1 (TGF-beta1) level, and number of nasal eosinophils (EOS) in rats with AR, so as to explore its underlying mechanisms. METHODS: Forty male Wistar rats were randomly divided into normal control, model, medication and acupoint application groups (n=10 rats per group). The AR model was established by intraperitoneal (i.p.) injection of mixture solution of ovalbumin, aluminum hydroxide and normal saline (once every other day, for 7 times), and nasal drip plus spray inhalation of ovalbumin (on the following day of i.p., once daily for 9 days). For acupoint application, the prepared herbal paste (containing White Mustard Seed, Rhizoma Corydalis, unprocessed Radix Kansui, Herba Asari and ginger juice) was applied to bilateral "Feishu" (BL13), "Pishu" (BL20) and "Shenshu" (BL23) for 2 h, once every other day for 7 times. The rats in the medication group were given Fluticasone Propionate nasal spray daily for 14 days. Scores of nasal itching, sneezing and nasal discharge on the day after modeling and the ending of the intervention were used to evaluate behavioral changes. Enzyme linked immunosorbent assay (ELISA) was used to detect the levels of serum IgE and TGF-beta1, and the infiltration state of EOS in the nasal mucosa tissue was observed under light microscope after HE staining. RESULTS: After modeling and compared with the normal control group, the behavioral scores and the levels of serum IgE and TGF-beta1 were significantly higher (P<0.05), and the infiltration state of EOS got worse. Compared with the model group, the increased behavioral score and serum IgE and TGF-beta1 levels were evidently suppressed (P<0.05) and EOS infiltration severity in the nasal mucosa was obviously milder in both medication and acupoint application groups. No significant differences were found between the medication and acupoint application groups in behavioral score and serum IgE and TGF-beta1 levels (P>0.05). CONCLUSION: Acupoint application can improve the symptoms of AR rats, which may be associated with its effect in down-regulating the levels of serum IgE and TGF-beta1. FAU - Chen, Shan AU - Chen S AD - Department of Acupuncture and Moxibustion, The First Affiliated Hospital of Zhejiang University of Chinese Medicine, Hangzhou 310006, China; The First School of Clinical Medicine of Zhejiang University of Chinese Medicine, Hangzhou 310053. FAU - Jin, Yu-Tong AU - Jin YT AD - The First School of Clinical Medicine of Zhejiang University of Chinese Medicine, Hangzhou 310053. FAU - Zhu, Zheng-Yang AU - Zhu ZY AD - The First School of Clinical Medicine of Zhejiang University of Chinese Medicine, Hangzhou 310053. FAU - Wu, Ling-Tao AU - Wu LT AD - The First School of Clinical Medicine of Zhejiang University of Chinese Medicine, Hangzhou 310053. FAU - Xuan, Li-Hua AU - Xuan LH AD - Department of Acupuncture and Moxibustion, The First Affiliated Hospital of Zhejiang University of Chinese Medicine, Hangzhou 310006, China; The First School of Clinical Medicine of Zhejiang University of Chinese Medicine, Hangzhou 310053. LA - chi PT - Journal Article PL - China TA - Zhen Ci Yan Jiu JT - Zhen ci yan jiu = Acupuncture research JID - 8507710 RN - 0 (Transforming Growth Factor beta1) SB - IM MH - *Acupuncture Points MH - Animals MH - Male MH - Nasal Mucosa MH - Rats MH - Rats, Wistar MH - *Rhinitis, Allergic MH - Transforming Growth Factor beta1 OTO - NOTNLM OT - Acupoint application OT - Allergic rhinitis OT - Inflammatory regulation OT - TGF-beta1 EDAT- 2019/08/02 06:00 MHDA- 2019/08/08 06:00 CRDT- 2019/08/02 06:00 PHST- 2019/08/02 06:00 [entrez] PHST- 2019/08/02 06:00 [pubmed] PHST- 2019/08/08 06:00 [medline] AID - 10.13702/j.1000-0607.180369 [doi] PST - ppublish SO - Zhen Ci Yan Jiu. 2019 Jun 25;44(6):430-3. doi: 10.13702/j.1000-0607.180369.